Implementation of sentinel lymph node biopsy with blue dye outside a specialized center: Can we improve quality assurance?

Breast Journal

Volumn 11, Issue 2, 2005, Pages 103-107

  Peintinger, Florentia ^a   Reitsamer, Roland ^b   Ralph, George ^a  

^a General Hospital of Leoben   (Austria)

^b St Johanns Spital   (Austria)

Author keywords

Breast cancer; Learning curve; Quality assurance; Sentinel lymph node biopsy

Indexed keywords

DYE;

ACCURACY; ADULT; ARTICLE; AXILLA; BREAST CANCER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; QUALITY CONTROL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; SURGICAL TRAINING;

ADULT; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HOSPITALS, GENERAL; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; QUALITY ASSURANCE, HEALTH CARE; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 15444375396     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21538.x     Document Type: Article

References (29)

1. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-38.
2. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37:991-99.
3. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23-27.
4. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608-14.
5. Temple LK, Baron R, Cody HS, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002;9:654-62.
6. Veronesi U, Galimberti V, Zurrida S, et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454-58.
7. Cox CE, Haddad F, Bass S, et al. Lymphatic mapping in the treatment of breast cancer. Oncology 1998;12:1283-98.
8. Krag D, Weaver D, Ashikaja T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941-46.
9. Giuliano AE. Sentinel node biopsy: standard of care. Breast J 2003;9:S3-6.
10. Zervos EE, Saha S, Hoshaw-Wooward S, Wheatley GH, Burak WE. Localizing the sentinel node outside of a specialty center: success of a lymphatic mapping course in disseminating new technology. Ann Surg Oncol 2001;8:7-12.
11. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
12. Albertini JJ, Lyman GH, Cox C. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
13. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-40.
14. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998;85:991-93.
15. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-27.
16. Cserni G, Boross G, Baltas B. Value of axillary sentinel nodal status in breast cancer. World J Surg 2000;24:341-44.
17. Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L. Sentinel lymph node biopsy alone without axillary lymph node dissection - follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 2003;29:221-23.
18. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy. A model for implementation of new surgical techniques. Ann Surg 2001;234:292-300.
19. Tanis PJ, Nieweg OE, Hart OO, Kroon BB. The illusion of the learning phase for lymphatic mapping. Ann Surg Oncol 2002;9:142-47.
20. Tafra L. The learning curve and sentinel node biopsy. Am J Surg 2001;182:347-50.
21. De Kanter AY, van Geel AN, Paul MA, et al. Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control. Eur J Surg Oncol 2000;26:652-56.
22. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
23. Morrow M, Rademaker AW, Bethke KP, et al. Learning sentinel node biopsy. Results of a prospective randomized trial of two techniques. Surgery 1999;126:714-22.
24. Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2002;8:88-91.
25. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights. Updated international consensus on the primary therapy of early breast cancer. J Clin Oncol 2003;21:3357-65.
26. Bass S, Cox CE, Reintgen DS. Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am 1999;8:497-509.
27. Cox CE, Salud CJ, Cantor A, et al. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 2001;193:593-600.
28. Johnson JM, Orr RK, Moline SR. Institutional learning curve for sentinel node biopsy at a community teaching hospital. Am Surg 2001;67:1030-33.
29. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-53.